Literature DB >> 24080892

[Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].

Juan José Picazo1, Fernando González-Romo, Amós García Rojas, Emilio Peréz-Trallero, Pedro Gil Gregorio, Rafael de la Cámara, María Luisa Morató, Alejandro Rodríguez, José Barberán, Vicente Domínguez Hernández, Manuel Linares Rufo, Isabel Jimeno Sanz, José María Portolés, Francisco Sanz Herrero, Javier Espinosa Arranz, Valle García-Sánchez, María Galindo Izquierdo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24080892

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


× No keyword cloud information.
  12 in total

1.  Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar; Imma Hospital; Cinta de Diego; Eva Satué; Jordi Bladé; Xabier Ansa; Jorge A Guzmán; Elisabet Salsench; Francisca Ramos
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

2.  Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Authors:  J C Sanz; I Rodríguez-Avial; E Ríos; B Ramos; E Cercenado
Journal:  Infection       Date:  2013-12-22       Impact factor: 3.553

3.  Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study.

Authors:  O Ochoa-Gondar; I Hospital; A Vila-Corcoles; M Aragon; M Jariod; C de Diego; E Satue
Journal:  BMC Public Health       Date:  2017-06-29       Impact factor: 3.295

4.  Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.

Authors:  Angel Vila-Córcoles; Olga Ochoa-Gondar; Cinta de Diego; Eva Satué; Angel Vila-Rovira; Maria Aragón
Journal:  Euro Surveill       Date:  2019-07

5.  [Vaccine-related adverse reactions in immunocompromised patients and in special situations of a hospital Vaccine Unit].

Authors:  M Fernández-Prada; A Viejo-González; A Martínez-Torrón; C Martínez-Ortega; J Ruiz-Salazar; I Huerta-González
Journal:  Rev Esp Quimioter       Date:  2019-09-24       Impact factor: 1.553

6.  [Risk of pneumococcal disease in elderly patients with and without previous vaccination].

Authors:  María Flores-Copete; Ricardo Reolid-Martínez; Mónica López-García; Pilar Alcantud-Lozano; Esther Mudarra-Tercero; Milagros Azorín-Ras; María Del Campo-Giménez; M Candelaria Ayuso-Raya; Francisco Escobar-Rabadán
Journal:  Aten Primaria       Date:  2018-11-01       Impact factor: 1.137

7.  Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain.

Authors:  Jose Miguel Rodríguez González-Moro; Rosario Menéndez; Magda Campins; Nadia Lwoff; Itziar Oyagüez; María Echave; Javier Rejas; Fernando Antoñanzas
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

8.  [Consensus guidelines for the management of community acquired pneumonia in the elderly patient].

Authors:  Juan González Del Castillo; Francisco Javier Martín-Sánchez; Pedro Llinares; Rosario Menéndez; Abel Mujal; Enrique Navas; José Barberán
Journal:  Rev Esp Geriatr Gerontol       Date:  2014-05-27

9.  [Invasive pneumococcal infection prevention in asplenic patients].

Authors:  J Rodríguez-García; R Fernández-Santos; E Ruiz de Gopegui-Bordes; O Hidalgo-Pardo
Journal:  Rev Esp Quimioter       Date:  2020-01-03       Impact factor: 1.553

10.  [Antipneumococcal vaccination in Catalonian adults: Vaccine coverages and adequacy to distinct guideline recommendations].

Authors:  Olga Ochoa-Gondar; Ángel Vila-Córcoles; Cinta de Diego; Eva Satué; Angel Vila-Rovira; María Aragón
Journal:  Aten Primaria       Date:  2018-01-17       Impact factor: 1.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.